Skip to content

Combined fracture treatment showed better scores, without clear evidence of fracture prevention

In very old patients after vertebral fracture surgery, combined medication showed better pain, disability and bone-density measures; repeat-fracture differences were not statistically significant.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Patients receiving both menadione and zoledronic acid alongside calcitriol after kyphoplasty had better reported pain, disability and bone-density results than those receiving either added drug alone or basic treatment. However, repeat-fracture rates did not differ significantly between groups. Improved scores and density therefore should not be read as evidence that the combination prevented further fractures.

Keep in mind

The abstract does not describe randomization or blinding, gives no sizes for the pain or disability differences, and supplies no adverse-reaction results to support its favorable short-term safety claim.

THE NUMBERS, WITH CONTEXT

What researchers found

7.50% (3/40) versus 2.50% (1/40)

Repeat-fracture rates within 12 months

Both added drugs versus kyphoplasty plus calcitriol alone. The overall comparison among all treatment groups was nonsignificant (P > .05).

Medicine (Baltimore), 2025 · Original source ↓

Separate outcomes

Pain and disability were assessed with rating scales, while bone density and laboratory markers were also measured. The reported gains in these measures answer different questions from whether patients went on to sustain another fracture.

The fracture finding

The overall analysis did not show a statistically significant difference in repeat fractures. That finding is inconclusive: it establishes neither prevention by the combined treatment nor equivalence among the treatment options studied.

CHECK THE ORIGINAL

The original publication

Comparative study on the efficacy of menadione, zoledronic acid, and calcitriol in combination with PKP for the treatment of osteoporotic vertebral compression fractures in extremely elderly patients.

Yu H, Hou H, Jin Y
Medicine (Baltimore) · 2025

PubMed ID
41054075
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.